Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| RCAX | Tidal Trust II - Defiance Daily Target 2x Long Rcat ETF | $19.81 | $6.64 | 50.45% | 391.3K | - | $11.66$22.31 |
| RLYB | Rallybio | $9.65 | $2.11 | 28.04% | 2.3M | $40M | $1.76$10.70 |
| ASTH | Astrana Health | $25.98 | $5.65 | 27.79% | 527.4K | $1.0B | $18.08$34.80 |
| MVO | Mv Oil Trust | $2.63 | $0.56 | 27.06% | 1.1M | $24M | $0.97$6.60 |
| DFNS | Nukkleus | $2.23 | $0.47 | 26.42% | 3.5M | $51M | $1.76$26.21 |
| CRCG | Themes ETF Trust - Leverage Shares 2x Long Crcl Daily ETF | $3.03 | $0.63 | 26.04% | 22.6M | - | $0.95$20.92 |
| RCAT | Red Cat | $14.39 | $2.74 | 23.52% | 688.1K | $1.4B | $4.58$18.02 |
| USGO | U.s. GoldMining | $14.87 | $2.83 | 23.45% | 13.7K | $160M | $7.42$17.98 |
| ALMU | Aeluma | $19.08 | $3.61 | 23.34% | 19.8K | $279M | $5.79$25.88 |
| VG | Venture Global | $11.87 | $2.18 | 22.50% | 763K | $24B | $5.72$19.50 |
| PURR | Hyperliquid Strategies | $4.88 | $0.80 | 19.61% | 3.9M | $506M | $3.01$5.78 |
| SYPR | Sypris Solutions | $3.54 | $0.58 | 19.59% | 79K | $68M | $1.42$4.74 |
| JFB | Jfb Construction | $17.90 | $2.73 | 18.00% | 126.2K | $96M | $3.39$35.10 |
| SOLT | Volatility Shares Trust - 2x Solana ETF | $54.55 | $8.32 | 17.99% | 335.5K | - | $41.00$706.00 |
| CGEN | Compugen | $2.13 | $0.32 | 17.40% | 750.5K | $169M | $1.13$2.38 |
| OCC | Optical Cable | $6.53 | $0.96 | 17.20% | 50.6K | $49M | $2.40$11.50 |
| AAOI | Applied Optoelectronics | $98.40 | $14.17 | 16.82% | 14.7M | $5.8B | $9.71$110.00 |
| CHNR | China Natural Resources | $3.77 | $0.54 | 16.72% | 125.5K | $4.0M | $3.16$8.20 |
| SRTS | Sensus Healthcare | $4.79 | $0.68 | 16.42% | 1.1K | $68M | $3.03$5.92 |
| ONDS | Ondas | $11.74 | $1.66 | 16.42% | 2.7M | $4.5B | $0.57$15.28 |
| LASR | nLIGHT | $65.28 | $9.09 | 16.18% | 78.8K | $3.1B | $6.20$67.65 |
| EMAT | Evolution Metals & Technologies | $9.15 | $1.18 | 14.81% | 75.7K | $23M | $5.50$24.37 |
| KLXE | KLX Energy Services | $2.90 | $0.36 | 14.17% | 191.7K | $45M | $1.46$5.29 |
| MGN | Megan | $2.26 | $0.26 | 13.00% | 53.1K | $33M | $1.00$8.63 |
| MRAL | GraniteShares ETF Trust - GraniteShares 2x Long Mara Daily ETF | $4.17 | $0.46 | 12.40% | 905.9K | - | $2.21$36.63 |
Related Articles
Featured Article
Why Ondas Holdings Stock Nearly Quadrupled Last Year
Jeremy Bowman|Jan 20, 2026
The company's move into autonomous drones began to gain traction.

1 Stock I'd Buy Before AeroVironment in 2026
Marc Guberti|Jan 12, 2026
AeroVironment is gaining market share thanks to an acquisition, but Ondas looks like the better drone stock for long-term investors.

Bold Prediction: Ondas Holdings Is About to Explode Higher. Here's the Smoking Gun.
Todd Shriber|Jan 5, 2026
Ondas Holdings is growing at a torrid pace, but the stock can continue flying higher as drone demand accelerates.

2 Stocks That Can Turn $100,000 Into $1 Million by 2035
Marc Guberti|Dec 16, 2025
Picking the right growth stock can produce life-changing returns

Why Venture Global Fell Back to Its April Lows in November
Billy Duberstein|Dec 8, 2025
Venture Global lowered full-year guidance as its legal troubles mount.

3 Incredible Growth Stocks to Buy Now
George Budwell, PhD|Dec 7, 2025
These tiny companies at the frontier of autonomous drones, sidewalk robotics, and quantum computing offer option-like upside for investors willing to stomach the volatility.

Is Ondas Holdings Stock a Buy?
George Budwell, PhD|Nov 20, 2025
This defense technology stock sits at the intersection of three powerful secular trends driving military and industrial spending.

3 Top 5G Stocks to Buy in September
5G networks have made nationwide debuts, but these hardware stocks could have the most to gain.

2 Top Biotech Picks for May
Zhiyuan Sun|May 20, 2020
Here are the hottest companies coming up in the biotech sector.

Can This Biotech Shed New Light on Cancer Immunotherapies?
Zhiyuan Sun|May 4, 2020
Its new discovery in the field of cancer immunotherapy produced mixed clinical results, but it certainly has ample backing from the big players.
